Gautier, Benoit, 1983-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Benoit Gautier researcher, ORCID id # 0000-0002-8249-2525
VIAF ID: 218532041 ( Personal )
Permalink: http://viaf.org/viaf/218532041
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A |
|
| Biochemical and biological assessment of VEGF receptors' antagonists with anti-angiogenic properties. |
|
| Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A. |
|
| Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. |
|
| Design, synthesis, and biological evaluation of the first podophyllotoxin analogues as potential vascular-disrupting agents. |
|
| Development of a chemiluminescent screening assay for detection of vascular endothelial growth factor receptor 1 ligands |
|
| Disulfide and amide-bridged cyclic peptide analogues of the VEGF81–91 fragment: Synthesis, conformational analysis and biological evaluation |
|
| Evaluation biochimique et biologique d'antagonistes des récepteurs au VEGF à visée anti-angiogénique |
|
| Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates. |
|
| Parallel solid-phase synthesis of a small library of linear and hydrocarbon-bridged analogues of VEGF(81-91): potential biological tools for studying the VEGF/VEGFR-1 interaction. |
|
| Structure-based design of a bicyclic peptide antagonist of the vascular endothelial growth factor receptors. |
|
| Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential. |
|
